The WACC of Xphyto Therapeutics Corp (XPHY.CN) is 8.6%.
| Range | Selected | |
| Cost of equity | 7.10% - 10.70% | 8.90% |
| Tax rate | 1.80% - 2.40% | 2.10% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.0% - 10.2% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.6% | 4.1% |
| Equity market risk premium | 5.5% | 6.5% |
| Adjusted beta | 0.65 | 0.95 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.10% | 10.70% |
| Tax rate | 1.80% | 2.40% |
| Debt/Equity ratio | 0.09 | 0.09 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.0% | 10.2% |
| Selected WACC | 8.6% | |